Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups
Mustapha Abubakar, Montserrat García‐Closas(Institute of Cancer Research), Minouk J. Schoemaker(Institute of Cancer Research), Marjanka K. Schmidt(University of Cambridge), Douglas Easton(University of Cambridge), Stephen M. Hewitt(National Institutes of Health), Laura van ‘t Veer, Penny Coulson(Institute of Cancer Research), Fergus J. Couch(Mayo Clinic), Frances Daley(Breast Cancer Now), Jelle Wesseling(Leiden University Medical Center), Jenny Chang‐Claude(Universität Hamburg), Michael E. Jones(Institute of Cancer Research), Jonine D. Figueroa, Anthony J. Swerdlow(Institute of Cancer Research), Flora E. van Leeuwen(The Netherlands Cancer Institute), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Carolien H. M. van Deurzen(Erasmus MC), Roger L. Milne(The University of Melbourne), H. Raza Ali(University of Zurich), Peter Devilee(Leiden University), Javier Benı́tez(Spanish National Cancer Research Centre), Antoinette Hollestelle(Erasmus MC Cancer Institute), Mitch Dowsett(Institute of Cancer Research), John W.M. Martens(Erasmus MC), Maartje J. Hooning(Erasmus MC Cancer Institute), Fiona M. Blows(University of Cambridge), Nick Orr(United States Department of Health and Human Services), Hermann Brenner(Universidad de Granada), Anja Rudolph(Institut für Qualität im Management (Germany)), Paul D.P. Pharoah(Cedars-Sinai Medical Center), Qin Wang(University of Cambridge), Caroline Seynaeve(Radboud University Nijmegen), Christa Stegmaier(Karolinska University Hospital), Mark E. Sherman(National Cancer Institute), kConFab Investigators, Manjeet K. Bolla(University of Cambridge), Jolanta Lissowska, Diana Eccles(Princess Anne Hospital), Hans‐Peter Sinn(Heidelberg University)
Cited by 79
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k